In some cases, methods of molecular diagnostics are used to further classify tumors, for example based
on certain gene mutations.
Researchers have
identified certain gene mutations that are indicative of an increased likelihood of thyroid cancer, and the molecular testing panel developed at UPMC can be run using the sample collected through the initial, minimally invasive biopsy, rather than a lobectomy.
Recent research also has illuminated how the deadly cascade that leads to brain atrophy is set in motion: The buildup of amyloid plaques, working in tandem
with certain gene mutations, sparks the formation of the renegade tau proteins.
Certain gene mutations may impede the ability of nerve cells in the brain to communicate effectively.
Certain gene mutations may impede the ability of nerve cells in the brain to communicate effectively.